Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007341
Chunk: 83

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 83
---
overning any deposited securities may require disclosure of or impose limits on beneficial or other ownership of, or interest in, deposited
securities, other Ordinary Shares and other securities and may provide for blocking transfer, voting or other rights to enforce such disclosure
or limits, you as ADR holders or beneficial owners agree to comply with all such disclosure requirements and ownership limitations and
to comply with any reasonable instructions we may provide in respect thereof We reserve the right to instruct ADR holders (and through
any such ADR holder, the beneficial owners of Depositary Shares evidenced by the ADRs registered in such ADR holder’s name) to deliver
their Depositary Shares for cancellation and withdrawal of the deposited securities so as to permit us to deal directly with the ADR holder
and/or beneficial owner of Depositary Shares as a holder of shares and, by holding a Depositary Share or an interest therein, ADR holders
and beneficial owners of Depositary Shares will be agreeing to comply with such instructions.

Each ADR holder agrees to provide such information
as the Company may request in a disclosure notice, or a Disclosure Notice, given pursuant to the Companies Act or the Articles of Association
of the Company. Each ADR holder acknowledges that it understands that failure to comply with a Disclosure Notice may result in the imposition
of sanctions against the holder of the underlying Ordinary Shares in respect of which the non-complying person is or was, or appears to
be or has been, interested as provided in the Companies Act and the Articles of Association which currently may include, subject to the
granting of an appropriate order by the court, the withdrawal of the voting rights of such Ordinary Shares and the imposition of restrictions
on the rights to receive dividends on and to transfer such Ordinary Shares. In addition, each ADR holder agrees to comply with the provisions
of the Disclosure Guidance and Transparency Rules published by the United Kingdom Financial Conduct Authority (as amended from time to
time) with regard to the notification to the Company of interests in Ordinary Shares underlying Depositary Shares and certain financial
instruments, which currently provide, inter alia, that an ADR holder must notify the Company of the percentage of its voting
rights he holds as a shareholder or holds or is deemed to hold through his direct or indirect holding of certain financial instruments
(or a combination of such holdings) if the percentage of those voting rights reaches, exceeds or falls below specified thresholds.

Books of Depositary

The depositary or its agent will maintain
a register for the registration,